Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Brain Neoplasms 3Carcinoma, Hepatocellular 2Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Leiomyoma 1Glioma 1Fibroadenoma 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1

Interventions

Tamoxifen 2gadoterate meglumine 1evening primrose oil 1Surgical Procedures, Operative 1Anesthesia, General 1Anesthesia, Epidural 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibroadenoma × gadoterate meglumine × Clear all
NCT04341129 2023-12-05

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

University of Chicago

Phase EARLY_PHASE1 Completed
50 enrolled
Breast

Breast Diseases, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Fibroadenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡